Pricing Log in Create free account

Annovis Bio, Inc. (ANVS) vs Celularity, Inc. (CELU)

Annovis Bio, Inc. and Celularity, Inc. are both Biotechnology companies. Annovis Bio, Inc. and Celularity, Inc. are of similar size ($44.8M and $43.2M). Annovis Bio, Inc. has the higher net margin (0.00% vs −375.9%) and the higher return on invested capital (0.00% vs −695.7%). Across the 12 metrics below, Annovis Bio, Inc. leads on 7 and Celularity, Inc. on 5.

Valuation

Metric ANVS CELU Biotechnology median
P/E n/m n/m 8.50
P/S n/m 1.92 9.71
P/B n/m n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 4.06 9.21
Earnings yield (180.81%) (217.31%) (33.15%)
Free cash flow yield (116.68%) (24.70%) (25.50%)

Profitability

Metric ANVS CELU Biotechnology median
Gross margin — 5.26% 65.16%
Operating margin 0.00% (321.32%) 0.00%
Net margin 0.00% (375.89%) 0.00%
Free cash flow margin 0.00% (46.46%) 0.00%
Return on equity (703.68%) 349.83% (56.36%)
Return on assets (227.74%) (62.45%) (48.04%)
Return on invested capital 0.00% (695.71%) 0.00%

Growth

Metric ANVS CELU Biotechnology median
Revenue growth (TTM) — (62.78%) 6.02%
EPS growth (last fiscal year) 39.39% (35.71%) 30.26%
Revenue growth, 5-year CAGR — 13.21% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ANVS CELU Biotechnology median
Debt to equity 0.00 (1.17) 0.00
Current ratio 3.47 0.09 4.72
Net debt to EBITDA 0.66 (0.77) 0.96

Dividend

Metric ANVS CELU Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ANVS CELU Biotechnology median
Market cap 44.81m 43.16m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack